Literature DB >> 13601406

Chemotherapy of cancer.

K A NEWTON.   

Abstract

Entities:  

Keywords:  NEOPLASMS/therapy

Mesh：

Year:  1958        PMID： 13601406      PMCID： PMC2501637          DOI： 10.1136/pgmj.34.398.622

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  25 in total

1.  Clinical studies on 6-mercaptopurine.

Authors:  J H BURCHENAL; R R ELLISON; M L MURPHY; D A KARNOFSKY; M P SYKES; T C TAN; A C MERMANN; M YUCEOGLU; W P MYERS; I KRAKOFF; N ALBERSTADT
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  The chemistry and biochemistry of purine analogs.

Authors:  G H HITCHINGS; G B ELION
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

3.  [Clinical experiences with sarcolysin in neoplastic diseases].

Authors:  N BLOKHIN; L LARIONOV; N PEREVODCHIKOVA; L CHEBOTAREVA; N MERKULOVA
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

4.  Hematological changes following treatment with p-(di-2-chlorethylamino)-phenylbutyric acid (CB 1348) in cancer. I. Effect on lymphocytes and platelets.

Authors:  E K PILLERS; S I MAGALINI
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

5.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

6.  Clinical observations on the use of triethylenemelamine.

Authors:  E D BAYRD; J M STICKNEY; B E HALL; C H WATKINS
Journal:  Cancer       Date:  1952-03       Impact factor: 6.860

7.  Triethylene melamine in the treatment of neoplastic disease.

Authors:  R W RUNDLES; W B BARTON
Journal:  Blood       Date:  1952-05       Impact factor: 22.113

8.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962

9.  An experimental study of triethylenethiophosphoramide (TSPA) in the prevention of postoperative pulmonary metastases.

Authors:  W M KRAMER; W E SCHATTEN
Journal:  Cancer       Date:  1958 May-Jun       Impact factor: 6.860

10.  Prevention of experimental lung metastases with triethylenethiophosphoramide (thio TEPA).

Authors:  W M KRAMER; R V ECK; R R SMITH
Journal:  Surg Gynecol Obstet       Date:  1958-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.